文献速递MDS 与骨髓增殖性肿瘤白血病

全基因组测序揭示骨髓增殖性肿瘤纤维化或白血病转化中的动态克隆变化及纤维化转化中的新型FOXP1突变

Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation.
PubMed 文献 · Leukemia · 2025-03-31

对20例骨髓增殖性肿瘤(MPN)患者慢性期及纤维化或白血病转化期样本行全基因组测序,在14例继发性骨髓纤维化患者中3例(21.4%)检出FOXP1突变,独立队列35例中另5例(14.3%)检出;8例FOXP1突变患者中位随访5.1年均未发生白血病转化;纤维化或白血病转化期检出非经典MPLY591突变,18例中线性克隆演化11例、分支演化7例。

要点

  • 继发性骨髓纤维化患者中FOXP1突变检出率为21.4%(3/14),独立队列为14.3%(5/35)。
  • 8例FOXP1突变患者中位随访5.1年均未发生白血病转化。
  • 纤维化或白血病转化期可检出非经典MPLY591突变,18例中线性克隆演化11例、分支演化7例。

核心结论

  • 携带FOXP1突变的MPN患者似乎不太可能发生白血病转化。
  • 特定基因突变的获得及克隆结构的动态变化是MPN转化患者发病机制的基础。

研究设计与样本

  • 对20例MPN患者慢性期及纤维化或白血病转化期样本行全基因组测序。
  • 另在35例独立队列患者中验证FOXP1突变。

主要发现

  • 14例继发性骨髓纤维化患者中3例(21.4%)检出FOXP1突变。
  • 独立队列35例中另5例(14.3%)检出FOXP1突变。
  • 8例FOXP1突变患者中位随访5.1年均未发生白血病转化。
  • 纤维化或白血病转化期检出非经典MPLY591突变。
  • 18例中线性克隆演化11例、分支克隆演化7例;克隆扩增涉及已知驱动基因18例、未知驱动基因2例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myeloproliferative neoplasms (MPNs) are characterized by clonal proliferation of hematopoietic stem cells, which can lead to secondary myelofibrosis or acute myeloid leukemia. We explored the changes in genomic alterations during MPN transformation using whole-genome sequencing of samples from both the chronic and fibrotic or leukemic phases of 20 patients. We identified FOXP1 mutations in 3 of 14 (21.4%) patients with secondary myelofibrosis. This novel mutation was identified in another 5 of the 35 patients (14.3%) in an independent cohort. All these 8 patients with FOXP1 mutations did not experience leukemic transformation after a median follow-up of 5.1 years. The acquisition of non-canonical MPLY591 mutations was detected in the fibrotic or leukemic phase. Clonal expansion, involving both known and unknown driver genes (in 18 and 2 patients, respectively), was observed in all patients. We determined the patterns of clonal evolution based on myeloid driver mutations in 18 patients: linear clonal evolution in 11 patients and branched clonal evolution in 7 patients. Our results suggested that MPN patients carrying FOXP1 mutations are unlikely to have leukemia transformation and emphasized that the acquisition of specific genetic mutations and dynamic changes in clonal architecture underlie the pathogenesis in patients undergoing MPN transformation.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Takamori H, Huang YJ, Fukushima H, et al. Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation. Leukemia. 2025. PMID: 40164719. doi:10.1038/s41375-025-02576-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。